Parkman Healthcare Partners LLC acquired a new stake in shares of BioMarin Pharmaceutical Inc. ( NASDAQ:BMRN – Get Rating ) in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 42,961 shares of the biotechnology company's stock, valued at approximately $3,642,000. Other institutional investors have also recently made changes to their positions in the company. Rhumbline Advisers raised its holdings in shares of BioMarin Pharmaceutical by 17.

https://www.dailypolitical.com/2023/03/06/parkman-healthcare-partners-llc-takes-position-in-biomarin-pharmaceutical-inc-nasdaqbmrn.html

#dailypolitical